Foster Wheeler to design Alcon's new pharma plant in Singapore
Foster Wheeler’s US subsidiary, Biokinetics, Inc, along with Foster Wheeler’s Singapore office, have been awarded a contract by Alcon Laboratories Inc. to provide engineering and architectural services for the conceptual and basic design of its new 250,000 sq ft manufacturing facility to be located in the Tuas Biomedical Park in Singapore.
The plant will produce ophthalmic pharmaceuticals for distribution throughout Asia. The Foster Wheeler contract value, was not disclosed.
Biokinetics, Inc was acquired by Foster Wheeler in 2008, and is a specialist in process systems design for the biopharmaceutical industry. Biokinetics is headquartered in Philadelphia, Pennsylvania, with additional operations in Emeryville, California, USA and Carlow, Ireland.
